BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36064796)

  • 1. Transitioning cancer cells and the surrounding tumor environment in pancreatic cancer.
    Nat Genet; 2022 Sep; 54(9):1269-1270. PubMed ID: 36064796
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma: 2. Pathogenesis and pathobiology in pancreatic cancer.--The molecular mechanisms of carcinogenesis, and invasion and metastasis in pancreatic cancer].
    Satoh K; Shimosegawa T
    Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):7-16. PubMed ID: 22413456
    [No Abstract]   [Full Text] [Related]  

  • 3. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation.
    Komori T; Ishikawa O; Ohigashi H; Yamada T; Sasaki Y; Imaoka S; Nakaizumi A; Uehara H; Tanaka S; Mano Y; Kasugai T
    Jpn J Clin Oncol; 2002 Apr; 32(4):146-51. PubMed ID: 12072425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer.
    Kuuselo R; Savinainen K; Sandström S; Autio R; Kallioniemi A
    Int J Cancer; 2011 Dec; 129(11):2553-65. PubMed ID: 21225629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into pancreatic cancer biology.
    Hidalgo M
    Ann Oncol; 2012 Sep; 23 Suppl 10():x135-8. PubMed ID: 22987949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer: factors regulating tumor development, maintenance and metastasis.
    Shi X; Friess H; Kleeff J; Ozawa F; Büchler MW
    Pancreatology; 2001; 1(5):517-24. PubMed ID: 12120231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
    Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
    Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology and molecular genetics of pancreatic neoplasms.
    Wood LD; Hruban RH
    Cancer J; 2012; 18(6):492-501. PubMed ID: 23187835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in pancreatic cancer: implications of phenotypic and molecular plasticity.
    Reddy JK; Rao MS
    Lab Invest; 1995 Apr; 72(4):383-6. PubMed ID: 7723275
    [No Abstract]   [Full Text] [Related]  

  • 10. Perineural invasion and associated pain in pancreatic cancer.
    Bapat AA; Hostetter G; Von Hoff DD; Han H
    Nat Rev Cancer; 2011 Sep; 11(10):695-707. PubMed ID: 21941281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: Current research and future directions.
    Falasca M; Kim M; Casari I
    Biochim Biophys Acta; 2016 Apr; 1865(2):123-32. PubMed ID: 26794394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts.
    Sato N; Maehara N; Goggins M
    Cancer Res; 2004 Oct; 64(19):6950-6. PubMed ID: 15466186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.
    Gao Y; Zhu Y; Yuan Z
    Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of pancreatic cancer.
    Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE
    Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling.
    Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Miyazaki K
    Ann Surg Oncol; 2007 Sep; 14(9):2600-7. PubMed ID: 17534684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cancer stem cells in pancreatic ductal adenocarcinoma.
    Sergeant G; Vankelecom H; Gremeaux L; Topal B
    Nat Rev Clin Oncol; 2009 Oct; 6(10):580-6. PubMed ID: 19687789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAK4 pathway as a potential therapeutic target in pancreatic cancer.
    Thillai K; Sarker D; Wells C
    Future Oncol; 2018 Mar; 14(7):579-582. PubMed ID: 29508632
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteonectin influences growth and invasion of pancreatic cancer cells.
    Guweidhi A; Kleeff J; Adwan H; Giese NA; Wente MN; Giese T; Büchler MW; Berger MR; Friess H
    Ann Surg; 2005 Aug; 242(2):224-34. PubMed ID: 16041213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer.
    Zhang L; Chenwei L; Mahmood R; van Golen K; Greenson J; Li G; D'Silva NJ; Li X; Burant CF; Logsdon CD; Simeone DM
    Cancer Res; 2006 Jan; 66(2):898-906. PubMed ID: 16424023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.
    Koizumi M; Hiasa Y; Kumagi T; Yamanishi H; Azemoto N; Kobata T; Matsuura B; Abe M; Onji M
    PLoS One; 2013; 8(8):e71367. PubMed ID: 23940742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.